FUDANZHANGJIANG Maintains Stable Share Structure in May 2026 Monthly Return

Bulletin Express
Jun 03

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. filed its Monthly Return for the period ended 31 May 2026, confirming that no movements occurred in either its Hong Kong-listed H shares or Shanghai STAR Market A shares. The report was lodged with Hong Kong Exchanges and Clearing Limited on 3 June 2026.

The company’s issued share structure remained unchanged: • H shares: 326.00 million outstanding, representing registered capital of RMB 32.60 million. • A shares: 710.57 million outstanding, representing registered capital of RMB 71.06 million.

Aggregate registered share capital stayed at RMB 103.66 million, reflecting a par value of RMB 0.10 per share across both classes.

Management confirmed that the H-share public float continues to meet the Hong Kong Exchange’s minimum requirement of 5 % of the class’s issued shares.

No share options, warrants, convertible instruments, treasury shares, repurchases, or other equity-related movements were recorded during the month.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10